A recent large-scale, genome-wide association study of single nucleotide polymorphisms showed a strong association between susceptibility to myocardial infarction and the Thr26Asn polymorphism in the lymphotoxin-a (LTA) gene. In the present study, we investigated whether the LTA Thr26Asn polymorphism was associated with the extent of coronary atherosclerosis in a large cohort (n ¼ 1082) of well-documented coronary artery disease patients. Thr26Asn genotypes showed a significant different distribution in male patients, when stratified according to the number of diseased coronary arteries, with an odds ratio of 1.98 (95% CI 1.22-3.22) for multiple-vessel disease in patients of the Asn/Asn genotype, compared with patients of the Thr/Thr or Thr/Asn genotype (P ¼ 0.006). Thus, further to the recent finding that LTA gene variation is associated with susceptibility to coronary heart disease, the present study provides evidence of an association between LTA genotype and the extent of coronary atherosclerosis.
Twin studies have indicated a significant genetic influence on the development of coronary artery disease (CAD). 1 The genetic basis for several Mendelian disorders that can lead to early-onset CAD has been elucidated, exemplified by familial hypercholesterolaemia which is caused by mutations in the low-density lipoprotein receptor gene. 2, 3 However, these Mendelian disorders only account for a small percentage of CAD patients. In the majority of cases, the disease is a result of the combined effect of multiple genetic and environmental factors, where each of the genetic factors makes a moderate contribution. [2] [3] [4] [5] Recently, a large-scale, genome-wide association study of 65 671 gene-based single nucleotide polymorphisms in relation to myocardial infarction, a severe condition of CAD, was performed in a large group of Japanese cases (n ¼ 1133) and two control groups (n ¼ 1006 and 872, respectively). The study showed a strong association between susceptibility to myocardial infarction and polymorphisms in a 50 kb genomic region on chromosome 6p21 that contains the lymphotoxin-a (LTA) gene. 6 Among the polymorphisms examined, 804C4A (Thr26Asn) in exon 3 of the LTA gene showed the strongest association with the disease. 6 The association of the Thr26Asn polymorphism with susceptibility to CAD has been confirmed in a recent study of 400 Caucasian trio families, using the transmission disequilibrium test (TDT) method. 7 Inflammation plays important roles in both the development and progression of atherosclerosis, the vascular lesion underlying the majority of CAD. 8, 9 LTA is an important proinflammatory cytokine and is expressed in atherosclerotic lesions. 10 It has been shown that LTA can induce the expression of a number of adhesion molecules and cytokines that are involved in atherogenesis. 6 Studies in mice fed an atherogenic diet showed that the area of atherosclerosis lesion in the aorta was significantly reduced (three-fold less) in LTA À/À mice than in LTA wild-type mice. 10 In this study, we examined the LTA gene Thr26Asn polymorphism in a cohort (n ¼ 1082) of Caucasian patients with angiographically confirmed coronary atherosclerosis and investigated whether this genetic variation was associated with the extent of coronary atherosclerosis. The study was approved by the local research ethics committee, and all subjects gave written consent. The characteristics of these patients have been described previously. 11 Coronary angiograms were analyzed by a consultant cardiologist. The coronary arteries, divided into 16 segments, were examined for the presence of stenosis. Of the 1082 patients, 445 had 450% stenosis in one coronary artery (one vessel disease), 356 had 450% stenosis in two coronary arteries (two vessel disease), and 272 had 450% stenosis in three coronary arteries (three vessel disease). DNA was extracted from peripheral blood samples using the 'salting out' method, and the LTA gene 804C4A (Thr26Asn) polymorphism genotyped using the Amplifluor single nucleotide polymorphism genotyping system. Statistical analyses were carried in the sample as a whole, and then separately in male patients and female patients. The w 2 test with one degree of freedom was used to test whether the observed genotype frequencies deviated from Hardy-Weinberg equilibrium. Logistic regression analysis was used to examine differences in genotype frequency between patient groups with singlevessel disease (SVD) or multiple-vessel disease (MVD), adjusting for classic cardiovascular risk factors including age, body mass index, smoking, cholesterol levels, triglyceride levels, hypertension, diabetes and family history of CAD.
LTA Thr26Asn genotype frequencies are showed in Table 1 . The frequency of the Asn26 allele was 0.368 (95% CI 0.347-0.389), which is slightly higher than the frequency of 0.30 (0.27-0.33) in the family trios each consisting of a CAD patient and their parents, 7 but slightly lower than the frequency of 0.41 (0.34-0.44) in the Japanese myocardial infarction cases. 6 The genotype distribution in patients with the SVD was in HardyWeinberg equilibrium. In patients with the MVD (including two vessel disease and three vessel disease), the genotype distribution deviated from Hardy-Weinberg equilibrium, which is likely to be due to the association between the Asn/Asn genotype and MVD as described below, and is unlikely to be due to genotyping error in the MVD group because DNA samples from patients with SVD and those from patients with MVD were randomly distributed in microplates during genotyping.
In the sample as a whole, the frequency of the Asn/Asn genotype was higher in patients with MVD than in patients with SVD, whereas the Thr/Thr and Thr/Asn genotypes were more prevalent in the SVD group than in the MVD group (Table 1) . This association was more pronounced when only the male patients were analyzed, with 6.5% higher frequency of the Asn/Asn genotype in patients with MVD than in patients with SVD (P ¼ 0.01, Table 1 ). A logistic regression analysis showed that in males patients, the odds ratio for MVD was 1.98 (95% CI (Table 2 ). That only homozygosity for the Asn allele was more prevalent in the MVD group than in the SVD group suggests a recessive effect of the Asn26 allele, which is consistent with findings form the study by Ozaki et al, 6 who showed a recessive effect of the Asn26 allele on risk of myocardial infarction in Japanese.
In females patients, no statistically significant difference in LTA Thr26Asn genotype frequency between the SVD and MVD groups was detected, but a trend towards lower frequency of the Asn/Asn genotype in the MVD group was noted. There are several possible explanations for the disparate findings in the male subjects and female subjects. First, this could be due to the small sample size of the female group. Second, this might reflect the different disease severity in the male and female subjects. The percentage of MVD was lower in the female subjects than in the male subjects (53.0% vs 61.3%, P ¼ 0.003), which is consistent with the widely recognized difference in coronary artery disease susceptibility and severity between the two genders. Third, there might be gender specific factors that modify the effect of LTA Thr26Asn genotype on the number of diseased vessels. Several other genes, the best documented being the apolipoprotein E gene, have been shown to have genderdependent genotype effect on cardiovascular traits. 12, 13 Thus, further to the recent studies showing an association of the Thr26Asn polymorphism with susceptibility to Lymphotoxin-a gene Thr26Asn polymorphism and coronary atherosclerosis R Laxton et al CAD, 6 ,7 the present study showed that men who are homozygous for the Asn allele are more likely to develop significant atherosclerosis in more than one coronary artery, than those of the Thr/Thr or Thr/Asn genotype. It has been proposed that for multifactorial diseases such as CAD, some genetic factors, referred to as susceptibility genes, influence the initiation of the disease process, while the same or other genetic factors, referred to as modifying genes, impact on the progression of the disease after it has been initiated.
14 It appears that LTA gene variation is among the genetic factors that are related to both susceptibility to and progression of CAD.
The association of the Thr26Asn polymorphism with CAD susceptibility and severity could be a result of a direct functional effect of this polymorphism or due to linkage disequilibrium of the Asn26 allele and a causative genetic variant located in the same genomic region. In the study by Ozaki et al, 6 who examined a number of polymorphisms in this genomic region, it was shown that it was the LTA gene, rather than NFKBIL1 or BAT1, that accounted for the association with myocardial infarction. In vitro experiments showed that the Asn26 isoform but not the Thr26 isoform induced the expression of selectin-E in coronary artery smooth muscle cells. 6 In addition, the expression of vascular celladhesion molecule-1 in coronary artery smooth muscle cells incubated with the Asn26 isoform was two-fold higher than that in the same type of cell incubated with the Thr26 isoform. 6 Both selectin-E and vascular celladhesion molecule-1 play an important role in the pathogenesis of atherosclerosis. 15 These findings suggest that the Thr26Asn polymorphism could have a direct functional effect in the development and progression of atherosclerosis.
In addition to LTA, several other genes encoding inflammatory mediators have been associated with CAD. For example, a recent study showed a linkage of myocardial infarction susceptibility with a locus on chromosome 13q12-13 which contains the 5-lipoxygenase activating protein gene, and that two of the haplotypes of this gene are associated with two-fold higher risk of the disease. 16 A functional polymorphism in the 5-lipoxygenase gene has also been associated with susceptibility to atherosclerosis. 17 5-Lipoxygenase activating protein and 5-lipoxygenase play key roles in the production of leukotrienes which are inflammatory mediators. 18 All these genetic findings are consistent with the important role of inflammation in the development and progression of atherosclerosis and its complications.
